Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FPQJ7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,662
Award facts
- Contract value 100% obligated
- $24,662.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,662.04 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. The award, issued on April 25, 2025, with an ultimate completion date of May 16, 2025, represents a direct procurement without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor. This delivery order falls under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026, which provides the agency with firm fixed-price ordering authority across a comprehensive portfolio of pharmaceutical products.
Stelara (ustekinumab) is a biologic medication used to treat various autoimmune and inflammatory conditions. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group maintains responsibility for distributing prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. The company's extensive contract portfolio with the Defense Logistics Agency under the SPE2DB program demonstrates its established capability to deliver specialized pharmaceutical products, including biologics and specialty medications, to support military health system requirements across the continental United States and globally.
Quick answers
Who was awarded contract SPE2DB25FPQJ7?
SPE2DB25FPQJ7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 25, 2025.
How much is contract SPE2DB25FPQJ7 worth?
The government has obligated $24,662 on SPE2DB25FPQJ7.
Is contract SPE2DB25FPQJ7 an order under another contract?
Yes. SPE2DB25FPQJ7 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPQJ7 competed?
The extent of competition for SPE2DB25FPQJ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award